VANESSA MATHIEU: Open Payments
NPI 1346547023 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 55 payments from 9 companies in 2025. Trend: 2023 $285 · 2024 $763 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $332 |
| Otsuka America Pharmaceutical, Inc. | 11 | $148 |
| Indivior Inc. | 4 | $87 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Alkermes, Inc. | 4 | $74 |
| Lundbeck LLC | 2 | $46 |
| Tris Pharma Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, FANAPT, Auvelity, VIVITROL, ABILIFY ASIMTUFII, LYBALVI.
Industry payments across WV — which companies pay providers there.
